Report Feature
The technologies in neuroprosthetic has undergone significant change in recent years, with cochlear implant based neuroprosthetic to spinal cord stimulation based neuroprosthetic. The rising wave of new technologies such as vagus nerve stimulation and spinal cord stimulation technology are creating significant potential for advanced neuroprosthetic devices in various medical platforms due to its benefits of reduction in the frequency of seizures and/or less medication with anti-seizure drugs.
In neuroprosthetic market, various technologies such as deep brain stimulation, vagus nerve stimulation, spinal cord stimulation, sacral nerve stimulation technologies are used in the motor neuron disorders, physiological disorders, and cognitive disorders applications. Increasing prevalence of neurological diseases such as traumatic brain injury, stroke, Parkinson’s disease, rise in geriatric population, and increase in healthcare expenditure are creating new opportunities for various neuroprosthetic technologies.
Some of the latest technological developments by various countries in the neuroprosthetic market are as follows:
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global neuroprosthetic technology by application, technology, and region as follows:
Technology Readiness by Technology Type
Competitive Intensity and Regulatory Compliance
Disruption Potential by Technology
Trends and Forecasts by Technology Type [$M shipment analysis from 2018 to 2030]:
Technology Trends and Forecasts by Application [$M shipment analysis from 2018 to 2030]:
Technology Trends and Forecasts by Region [$M shipment analysis for 2018 to 2030]:
Latest Developments and Innovations in the Neuroprosthetic Technologies
Companies/ Ecosystems
Strategic Opportunities by Technology Type
Some of the neuroprosthetic companies profiled in this report include Medtronic, Boston Scientific, and Cyberonics.
Below are the latest technological developments from top companies in the neuroprosthetic market:
Q.1 What are some of the most promising and high-growth technology opportunities for the neuroprosthetic market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in neuroprosthetic market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in neuroprosthetic market?
Q.6 What are the latest developments in neuroprosthetic technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this neuroprosthetic market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are the strategic growth opportunities in this neuroprosthetic technology space?
In neuroprosthetic market, various technologies such as deep brain stimulation, vagus nerve stimulation, spinal cord stimulation, sacral nerve stimulation technologies are used in the motor neuron disorders, physiological disorders, and cognitive disorders applications. Increasing prevalence of neurological diseases such as traumatic brain injury, stroke, Parkinson’s disease, rise in geriatric population, and increase in healthcare expenditure are creating new opportunities for various neuroprosthetic technologies.
Some of the latest technological developments by various countries in the neuroprosthetic market are as follows:
- United States: Medtronic and Abbott are leading initiatives in neuroprosthetic technology. Medtronic has announced advancements in deep brain stimulation (DBS) technology, with the development of closed-loop systems for personalized treatment of movement disorders like Parkinson's disease. Abbott has introduced innovative spinal cord stimulation (SCS) devices with advanced programming capabilities for chronic pain management.
- Germany: NeuroPace and Boston Scientific are investing in neuroprosthetic innovation. NeuroPace specializes in vagus nerve stimulation (VNS) systems for epilepsy management, with recent developments in closed-loop technology for seizure prediction and prevention. Boston Scientific has introduced sacral nerve stimulation (SNS) devices for bladder and bowel control, leveraging advanced stimulation algorithms for improved efficacy.
- Switzerland: LivaNova and SensArs are driving neuroprosthetic advancements. LivaNova specializes in DBS therapy for treatment-resistant depression, with recent developments in closed-loop neuromodulation systems. SensArs focuses on spinal cord stimulation (SCS) technology for restoring movement in individuals with spinal cord injuries, with innovative electrode designs for targeted stimulation.
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global neuroprosthetic technology by application, technology, and region as follows:
Technology Readiness by Technology Type
Competitive Intensity and Regulatory Compliance
Disruption Potential by Technology
Trends and Forecasts by Technology Type [$M shipment analysis from 2018 to 2030]:
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Sacral Nerve Stimulation
Technology Trends and Forecasts by Application [$M shipment analysis from 2018 to 2030]:
-
Motor Neuron Disorders
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Sacral Nerve Stimulation
-
Physiological Disorders
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Sacral Nerve Stimulation
-
Cognitive Disorders
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Sacral Nerve Stimulation
Technology Trends and Forecasts by Region [$M shipment analysis for 2018 to 2030]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- Japan
- China
- South Korea
- India
- The Rest of the World
Latest Developments and Innovations in the Neuroprosthetic Technologies
Companies/ Ecosystems
Strategic Opportunities by Technology Type
Some of the neuroprosthetic companies profiled in this report include Medtronic, Boston Scientific, and Cyberonics.
Below are the latest technological developments from top companies in the neuroprosthetic market:
- Medtronic recently announced the FDA approval of its Percept™ PC Deep Brain Stimulation (DBS) system for Parkinson's disease. The Percept™ PC system features BrainSense™ technology, allowing for brain signals to be recorded simultaneously with stimulation to provide more personalized therapy and insights into disease management.
- LivaNova launched its SenTiva® device for Vagus Nerve Stimulation (VNS) therapy in Europe. SenTiva® features the latest technology advancements, including the ability to detect and log events such as seizures, providing valuable data for patient management and treatment optimization.
- Abbott introduced its Proclaim™ XR SCS system with BurstDR™ stimulation, designed to provide long-lasting pain relief for patients suffering from chronic pain. The Proclaim™ XR system offers personalized therapy options and improved battery longevity, enhancing patient comfort and convenience.
- Axonics Modulation Technologies received FDA approval for its r-SNM® System for Sacral Neuromodulation (SNM) therapy. The r-SNM® System offers a miniaturized implantable neurostimulator with a long-lived, rechargeable battery, providing long-term relief for patients with overactive bladder and bowel dysfunction.
Q.1 What are some of the most promising and high-growth technology opportunities for the neuroprosthetic market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in neuroprosthetic market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in neuroprosthetic market?
Q.6 What are the latest developments in neuroprosthetic technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this neuroprosthetic market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are the strategic growth opportunities in this neuroprosthetic technology space?
Table of Contents
1. Executive Summary 2. Technology Landscape 2.1. Technology Background and Evolution 2.2. Technology and Application Mapping 2.3. Supply Chain
3. Technology Readiness 3.1. Technology Commercialization and Readiness 3.2. Drivers and Challenges in Neuroprosthetic Technologies 3.3. Competitive Intensity 3.4. Regulatory Compliance
4. Technology Trends and Forecasts Analysis from 2018-2030 4.1. Neuroprosthetic Opportunity 4.2. Technology Trends (2018-2023) and Forecasts (2024-2030)
5. Technology Opportunities (2018-2030) by Region 5.1. Neuroprosthetic Market by Region 5.2. North American Neuroprosthetic Technology Market
6. Latest Developments and Innovations in the Neuroprosthetic Technologies 7. Companies / Ecosystem 7.1. Product Portfolio Analysis 7.2. Market Share Analysis 7.3. Geographical Reach
8. Strategic Implications 8.1. Implications 8.2. Growth Opportunity Analysis
9. Company Profiles of Leading Players 9.1. Medtronic 9.2. Boston Scientific 9.3. Cyberonics
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
